These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27095572)

  • 1. Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100).
    Xu J; Wang Y; Hua X; Xu J; Tian Z; Jin H; Li J; Wu XR; Huang C
    Oncotarget; 2016 Jun; 7(23):34112-30. PubMed ID: 27095572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
    J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFκB2 p52 stabilizes rhogdiβ mRNA by inhibiting AUF1 protein degradation via a miR-145/Sp1/USP8-dependent axis.
    Xu J; Hua X; Jin H; Zhu J; Li Y; Li J; Huang C
    Mol Carcinog; 2019 May; 58(5):777-793. PubMed ID: 30604907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494.
    Wang Y; Xu J; Gao G; Li J; Huang H; Jin H; Zhu J; Che X; Huang C
    Oncogene; 2016 Aug; 35(31):4080-90. PubMed ID: 26686085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
    Peng M; Wang J; Zhang D; Jin H; Li J; Wu XR; Huang C
    Oncogene; 2018 Oct; 37(43):5735-5748. PubMed ID: 29930380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic role of
    Jin H; Ma J; Xu J; Li H; Chang Y; Zang N; Tian Z; Wang X; Zhao N; Liu L; Chen C; Xie Q; Lu Y; Fang Z; Huang X; Huang C; Huang H
    Autophagy; 2021 Apr; 17(4):840-854. PubMed ID: 32116109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.
    Zhang J; Warren MA; Shoemaker SF; Ip MM
    Endocrinology; 2007 Jan; 148(1):268-78. PubMed ID: 17008396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
    Xia H; Long J; Zhang R; Yang X; Ma Z
    Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation.
    Zhang R; Che X; Zhang J; Li Y; Li J; Deng X; Zhu J; Jin H; Zhao Q; Huang C
    Oncotarget; 2016 Oct; 7(41):66689-66699. PubMed ID: 27556506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-938 promotes colorectal cancer cell proliferation via targeting tumor suppressor PHLPP2.
    Li CF; Li YC; Jin JP; Yan ZK; Li DD
    Eur J Pharmacol; 2017 Jul; 807():168-173. PubMed ID: 28433657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.
    Jiang G; Huang C; Li J; Huang H; Wang J; Li Y; Xie F; Jin H; Zhu J; Huang C
    Carcinogenesis; 2018 Mar; 39(3):482-492. PubMed ID: 29409027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite.
    Wang F; Shi Y; Yadav S; Wang H
    Toxicology; 2010 Jun; 273(1-3):12-8. PubMed ID: 20420878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing.
    Kim JS; Kim EJ; Kim HS; Kurie JM; Ahn YH
    Biochem Biophys Res Commun; 2017 Sep; 491(2):337-342. PubMed ID: 28733031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.
    Fang Y; Cao Z; Hou Q; Ma C; Yao C; Li J; Wu XR; Huang C
    Mol Cancer Ther; 2013 Aug; 12(8):1492-503. PubMed ID: 23723126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
    Yeo SK; French R; Spada F; Clarkson R
    Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
    Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.